Back to results
US 11,634,478 B2Granted
Human immunodeficiency virus neutralizing antibodies and methods of use thereof
AssigneesThe Rockefeller University, California Institute of Technology
InventorsJohannes Scheid, Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin
Life of this patent
Estimating the term…
Abstract
The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.
Claims17
A polynucleotide comprising a nucleic acid sequence encoding an anti-HIV antibody or an HIV gp120-derived antigen-binding fragment thereof comprising the CDR1, CDR2, and CDR3 regions of the sequence of SEQ ID NO:
- 387 and the CDR1, CDR2, and CDR3 regions of the sequence of SEQ ID NO:
- 558.
Dependencies are inferred from the claim text.